Are you taking a daily PPI and still have GERD-associated heartburn symptoms? You could be eligible to participate in our study!

UVA Tracking #
HSR220460
Principal Investigator
Jeanetta Frye
Contact
Lakin Underwood
Contact Email
Contact Phone
434.924.0818
Official Trial Title
A RANDOMIZED, DOUBLE-BLIND, PLACEBOCONTROLLED, MULTI-CENTER STUDY OF PANOSYLISOMALTOOLIGOSACCHARIDES (PIMO) ADJUNCTIVE TO PROTON PUMP INHIBITOR (PPI) THERAPY TO TREAT GASTROESOPHAGEAL REFLUX DISEASE (GERD) IN SUBJECTS WHO ARE PPI-RESPONDERS OR PPI-PARTIAL
Study Description

The GI Research Department seeks adults ages 18-75 with GERD-associated heartburn symptoms who are taking a PPI 5-7 days/week and still experiencing heartburn. The investigational medication is a pre-biotic, lightly sweet liquid – just 1/3 teaspoon nightly. No pills or capsules.

You may be eligible for this study if you are 18-75 years old, taking a PPI and have an active email/internet access for filling out nightly questionnaires.

Study involves 4 office visits, lab tests (including blood draws and ECGs), taking the investigational drug or placebo, nightly questionnaires and endoscopy. All research-related tests and procedures are provided at no cost.

Study participation may last up to 3 months, and you will be compensated for your participation.

Compensation

$250